New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Healthcare Realty Trust Incorporated

HR

Real Estate Reit Healthcare Facilities

Healthcare Realty Trust Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 6.92% from fiscal 2024.

Revenue
−3.74%
EPS
n/m
Free cash flow
−65.2%
Total debt
+2.51%

Quarter to September 2026, against a year earlier

19.38 0.02 +0.10%

After hours trading: 19.36, down 0.10%, last trade 4:01pm Eastern.

Market cap
$6.6B
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
4.95%
F-score
5/9
ROIC
2.19%
Net debt / EBITDA
0.1×
Payout ratio
—

Ratios over time FY16 to FY25

Returns on capital

ROIC was 1.23% in FY25, against a low of −0.19% in FY22.

ROEROIC
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
ROE2.9%2.5%6.4%0.9%2.2%2.5%0.8%−3.8%−10.7%−4.9%
ROIC1.8%1.3%1.6%1.5%0.8%2.3%−0.2%0.5%0.4%1.2%

Debt

Net debt is 0.07× a year’s EBITDA. Debt is 0.02× equity, against 0.99× in FY16.

Debt / equityNet debt / EBITDA
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Debt / equity1.0×0.8×0.8×0.8×0.9×0.0×0.0×0.0×0.0×0.0×
Net debt / EBITDA6.3×7.3×5.7×6.3×10.7×0.0×0.0×0.1×0.0×0.1×

Cash cycle, in days

Customers pay in 184 days and suppliers are paid in 372. Suppliers fund 188 days of working capital.

Cash cycleDays to pay suppliersDays to be paid
FY16FY17FY18FY19FY20
Cash cycle−129−195−189−171−188
Days to pay suppliers267319306296372
Days to be paid137124117125184

Per share, from FY16

Since FY16, per share: revenue has grown 0.00% a year; book value has grown 0.28% a year.

RevenueBook value
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue1.0×1.0×1.0×1.0×1.1×1.1×1.1×1.1×1.0×1.0×
Book value1.0×1.4×1.2×1.3×1.9×1.2×2.3×1.4×1.1×1.0×
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
82.60 84.86 24.81 201.87 51.58 102.55 62.74 0.00 0.00 0.00
Piotroski F-Score
7 4 5 6 6 6 6 3 5 5
P/S ratio
8.57 8.76 7.49 9.00 7.38 8.91 5.32 4.89 4.89 5.02
P/FCF ratio
0.00 0.00 9.53 0.00 47.51 93.56 4.63 5.71 3.60 4.06
P/Operating CF
71.25 68.07 53.97 61.06 18.40 76.36 33.98 51.64 44.90 44.80
P/B ratio
2.22 1.60 1.56 1.82 1.14 2.18 0.65 0.95 1.17 1.27
EV/Sales
12.35 13.09 10.95 12.92 13.20 8.92 5.34 4.93 4.89 5.06
EV/EBITDA
20.54 22.17 18.04 32.00 24.25 16.81 11.47 8.31 6.32 8.78
EV/FCF
(14.07) (3.90) 13.93 (29.85) 84.97 93.74 4.64 5.75 3.60 4.09
Current Ratio
1.89 1.94 0.72 1.60 1.85 0.01 0.01 0.00 0.01 0.01
Net Debt/EBITDA
6.29 7.34 5.70 6.35 10.69 0.03 0.03 0.06 0.00 0.07
Debt/Equity
0.99 0.83 0.76 0.80 0.94 0.01 0.01 0.01 0.01 0.02
ROE
2.88% 2.49% 6.37% 0.89% 2.17% 2.46% 0.83% (3.81%) (10.71%) (4.93%)
ROA
1.33% 1.25% 3.38% 0.47% 1.08% 1.21% 0.45% (2.10%) (5.62%) (2.48%)
ROIC
1.81% 1.28% 1.64% 1.49% 0.81% 2.33% (0.19%) 0.49% 0.39% 1.23%
Return on Tangible Assets
1.28% 1.05% 3.80% 0.49% 1.15% 3.52% 0.59% (4.64%) (14.51%) (6.48%)
Average Days of Receivables
137.36 123.57 117.09 125.01 183.90 — — — — —
Earnings Yield
1.21% 1.18% 4.03% 0.50% 1.94% 0.98% 1.59% (4.27%) (10.50%) (4.19%)
Free Cash Flow Yield
(10.25%) (38.31%) 10.49% (4.81%) 2.10% 1.07% 21.58% 17.52% 27.80% 24.65%
Free Cash Flow per Share
(2.96) (11.38) 2.66 (1.46) 0.58 0.36 4.25 3.04 4.71 4.18
Book value per Share
13.03 18.58 16.18 16.68 24.15 15.32 30.43 18.26 14.50 13.36
Free Cash Flow
(404.70) (2,060.23) 547.27 (299.57) 77.64 50.91 1,071.29 1,152.08 1,722.70 1,461.62
EV/EBIT
55.86 65.02 50.45 61.05 83.07 58.37 0.00 122.33 185.19 64.32
Other line items

Show all line items

Columns are period end dates · fundamentals updated Nov 18, 2026